BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 27029459)

  • 1. A randomized phase I trial evaluating the effects of inhaled 50-50% N2 O-O2 on remifentanil-induced hyperalgesia and allodynia in human volunteers.
    Wehrfritz A; Schaefer S; Troester A; Noel N; Bessiere B; Apiou-Sbirlea G; Simonnet G; Schuettler J; Richebé P
    Eur J Pain; 2016 Oct; 20(9):1467-77. PubMed ID: 27029459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of antihyperalgesic and analgesic effects of 35% nitrous oxide when combined with remifentanil: A randomised phase 1 trial in volunteers.
    Wehrfritz A; Bauer M; Noel N; Ramirez-Gil JF; Ihmsen H; Prottengeier J; Schüttler J; Bessiere B
    Eur J Anaesthesiol; 2021 Dec; 38(12):1230-1241. PubMed ID: 34735395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans.
    Koppert W; Sittl R; Scheuber K; Alsheimer M; Schmelz M; Schüttler J
    Anesthesiology; 2003 Jul; 99(1):152-9. PubMed ID: 12826855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of remifentanil-induced postinfusion hyperalgesia by propofol.
    Singler B; Tröster A; Manering N; Schüttler J; Koppert W
    Anesth Analg; 2007 Jun; 104(6):1397-403, table of contents. PubMed ID: 17513631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans.
    Tröster A; Sittl R; Singler B; Schmelz M; Schüttler J; Koppert W
    Anesthesiology; 2006 Nov; 105(5):1016-23. PubMed ID: 17065897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II).
    Dieterle M; Zurbriggen L; Mauermann E; Mercer-Chalmers-Bender K; Frei P; Ruppen W; Schneider T
    Pain; 2022 Oct; 163(10):1919-1928. PubMed ID: 35239547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans.
    Lenz H; Raeder J; Draegni T; Heyerdahl F; Schmelz M; Stubhaug A
    Pain; 2011 Jun; 152(6):1289-1297. PubMed ID: 21396775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
    Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
    Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of remifentanil-induced postinfusion hyperalgesia by the β-blocker propranolol in humans.
    Chu LF; Cun T; Ngai LK; Kim JE; Zamora AK; Young CA; Angst MS; Clark DJ
    Pain; 2012 May; 153(5):974-981. PubMed ID: 22365565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia.
    Hood DD; Curry R; Eisenach JC
    Anesth Analg; 2003 Sep; 97(3):810-815. PubMed ID: 12933407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans.
    Luginbühl M; Gerber A; Schnider TW; Petersen-Felix S; Arendt-Nielsen L; Curatolo M
    Anesth Analg; 2003 Mar; 96(3):726-732. PubMed ID: 12598253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal.
    Angst MS; Koppert W; Pahl I; Clark DJ; Schmelz M
    Pain; 2003 Nov; 106(1-2):49-57. PubMed ID: 14581110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of remifentanil and gabapentin on hyperalgesia in a new extended inflammatory skin pain model in healthy volunteers.
    Gustorff B; Hoechtl K; Sycha T; Felouzis E; Lehr S; Kress HG
    Anesth Analg; 2004 Feb; 98(2):401-407. PubMed ID: 14742378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose buprenorphine infusion to prevent postoperative hyperalgesia in patients undergoing major lung surgery and remifentanil infusion: a double-blind, randomized, active-controlled trial.
    Mercieri M; Palmisani S; De Blasi RA; D'Andrilli A; Naccarato A; Silvestri B; Tigano S; Massullo D; Rocco M; Arcioni R
    Br J Anaesth; 2017 Oct; 119(4):792-802. PubMed ID: 29121294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of remifentanil on pain and secondary hyperalgesia associated with the heat--capsaicin sensitization model in healthy volunteers.
    Petersen KL; Jones B; Segredo V; Dahl JB; Rowbotham MC
    Anesthesiology; 2001 Jan; 94(1):15-20. PubMed ID: 11135717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Fentanyl Lead to Opioid-induced Hyperalgesia in Healthy Volunteers?: A Double-blind, Randomized, Crossover Trial.
    Mauermann E; Filitz J; Dolder P; Rentsch KM; Bandschapp O; Ruppen W
    Anesthesiology; 2016 Feb; 124(2):453-63. PubMed ID: 26655493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized study of the effect of oral lamotrigine and hydromorphone on pain and hyperalgesia following heat/capsaicin sensitization.
    Petersen KL; Maloney A; Hoke F; Dahl JB; Rowbotham MC
    J Pain; 2003 Sep; 4(7):400-6. PubMed ID: 14622682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative butorphanol and flurbiprofen axetil therapy attenuates remifentanil-induced hyperalgesia after laparoscopic gynaecological surgery: a randomized double-blind controlled trial.
    Zhang L; Shu R; Zhao Q; Li Y; Yu Y; Wang G
    Br J Anaesth; 2016 Oct; 117(4):504-511. PubMed ID: 28077539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of postoperative pain: clinical indications for a contribution of central neuronal sensitization.
    Dirks J; Møiniche S; Hilsted KL; Dahl JB
    Anesthesiology; 2002 Dec; 97(6):1591-6. PubMed ID: 12459689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AMPA/kainate antagonist LY293558 reduces capsaicin-evoked hyperalgesia but not pain in normal skin in humans.
    Sang CN; Hostetter MP; Gracely RH; Chappell AS; Schoepp DD; Lee G; Whitcup S; Caruso R; Max MB
    Anesthesiology; 1998 Nov; 89(5):1060-7. PubMed ID: 9821993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.